Menu
Home
Forums
New posts
Search forums
What's new
Featured content
New posts
New media
New media comments
New resources
Latest activity
Media
New media
New comments
Search media
Resources
Latest reviews
Search resources
Misc
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Home
Forums
Labrish
Nyuuz
UNAIDS Calls for Significant Price Cut on Lenacapavir to Ensure Global Access
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
[QUOTE="Munyaradzi Mafaro, post: 44265, member: 636"] The UNAIDS chief wants a company to slash the price of a new HIV prevention drug. Winnie Byanyima says the current cost of 28,218 dollars per person each year is way beyond what most people can afford. She believes the medicine should cost just 40 dollars annually to help poor countries fight the disease. The drug called lenacapavir works amazingly well at stopping HIV infections. Tests showed it prevented 100 percent of new cases among women and cut infections by 96 percent for other groups. Scientists can make the medicine for only 40 dollars per person but the company wants to charge much more. Byanyima asked world leaders to pressure the drug maker during upcoming meetings. She warned that African nations cannot pay such high prices when their HIV programs already face budget cuts. American aid programs have stopped sending money which makes the situation worse for many countries. Health experts worry that people will miss out on this breakthrough treatment just like previous HIV drugs. They want governments and companies to work together to get the medicine to everyone who needs it. The World Health Organization plans to release new guidelines about the drug soon. [/QUOTE]
Insert quotes…
Name
Post reply
Home
Forums
Labrish
Nyuuz
UNAIDS Calls for Significant Price Cut on Lenacapavir to Ensure Global Access
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top